Titolo	Autore(i)	Anno	Periodico	Editore	Tipo
1	Yttrium-90 ibritumomab tiuxetan as a single agent in patients with pretreated B-cell lymphoma: evaluation of the long-term outcome.	Zinzani P.L.; Gandolfi L.; Stefoni V.; Fanti S.; Fina M.; Pellegrini C.; Montini G.C.; Derenzini E.; Broccoli A.; Argnani L.; Pileri S.; Baccarani M.	2010	CLINICAL LYMPHOMA MYELOMA & LEUKEMIA		1.01 Articolo in rivista
2	Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.	Biasco G; Derenzini E; Grazi G; Ercolani G; Ravaioli M; Pantaleo MA; Brandi G.	2006	CANCER TREATMENT REVIEWS		1.01 Articolo in rivista
3	Treatment of colorectal cancer liver metastases	Derenzini E; Di Battista M; Di Marco MC; Dell'Arte S; Astorino M; Bertolini S; Brandi G; Biasco G.	2006	MINERVA MEDICA		1.01 Articolo in rivista
4	Therapeutic implications of intratumor heterogeneity for TP53 mutational status in Burkitt lymphoma	Derenzini, Enrico; Iacobucci, Ilaria; Agostinelli, Claudio; Imbrogno, Enrica; Storlazzi, Clelia Tiziana; L`abbate, Alberto; Casadei, Beatrice; Ferrari, Anna; GHELLI LUSERNA DI RORÀ, Andrea; Martinelli, Giovanni; Pileri, Stefano; Zinzani, PIER LUIGI	2015	EXPERIMENTAL HEMATOLOGY & ONCOLOGY		1.01 Articolo in rivista
5	The tratment of liver metastases from colorectal cancer: questions more than answers?	Biasco G; Derenzini E; Di Battista M; Brandi G	2004	GUVARISH		1.01 Articolo in rivista
6	The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma	Derenzini E; Iacobucci I; Brighenti E; Cattina F; Davis RE; Pileri S; Martinelli G; Baccarani M; Zinzani PL	2011	BLOOD		4.02 Riassunto (Abstract)
7	The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)	I Iacobucci; F Cattina; S Pomella; A Lonetti; E Derenzini; E Brighenti; A Ferrari; C Papayannidis; M Vittoria; V Falzacappa; V Guadagnuolo; M Aluigi; E Ottaviani; S Formica; M Abbenante; S Soverini; D Russo; F Pane; P Pellicci; M Baccarani; G Martinelli	2011	BLOOD		4.02 Riassunto (Abstract)
8	Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: A new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients	Trino, Stefania; Iacobucci, Ilaria; Erriquez, Daniela; Laurenzana, Ilaria; De Luca, Luciana; Ferrari, Anna; Ghelli Luserna Di Rorà, Andrea; Papayannidis, Cristina; Derenzini, Enrico; Simonetti, Giorgia; Lonetti, Annalisa; Venturi, Claudia; Cattina, Federica; Ottaviani, Emanuela; Abbenante, Maria Chiara; Russo, Domenico; Perini, Giovanni; Musto, Pellegrino; Martinelli, Giovanni	2016	ONCOTARGET		1.01 Articolo in rivista
9	Systemic adjuvant chemotherapy after resection of colorectal cancer metastases	G. Brandi; E. Derenzini; M.A. Pantaleo; M. Di Battista; M. Ravaioli; G. Ercolani; G.L. Grazi; S. Fanello; M. Di Marco; E. Nobili; R. Hakim; R. Poggi; E. Palmerini; G. Biasco	2004	ANNALS OF ONCOLOGY		1.06 Abstract in rivista
10	The synergistic efficacy of Chk1/Chk2 inhibitors and doxorubicin in the treatment of acute lymphoblastic leukemia	GHELLI LUSERNA DI RORÀ, Andrea; Iacobucci, Ilaria; Imbrogno, Enrica; Derenzini, Enrico; Ferrari, Anna; Robustelli, Valentina; Guadagnuolo, Viviana; Papayannidis, Cristina; Abbenante, Mariachiara; Grilli, Sandro; Martinelli, Giovanni	2016	CANCER RESEARCH		1.06 Abstract in rivista
11	Successful combination treatment of clofarabine, cytarabine, and gemtuzumab-ozogamicin in adult refractory B-acute lymphoblastic leukemia.	Papayannidis C; Derenzini E; Iacobucci I; Curti A; Paolini S; Cilloni D; Baccarani M; Martinelli G.	2009	AMERICAN JOURNAL OF HEMATOLOGY		1.01 Articolo in rivista
12	The small molecule CHK1/CHK2 inhibitor PF-0477736 (Pfizer) demonstrates single agent activity in diffuse large B-cell lymphoma	Derenzini, Enrico; Iacobucci, Ilaria; Brighenti, E; Cattina, Federica; Casadei, B; Davis, Re; Pileri, Stefano; Martinelli, Giovanni; Baccarani, Michele; Zinzani, PIER LUIGI	2012	CANCER RESEARCH	American Association for Cancer Research (AACR)	4.02 Riassunto (Abstract)
13	SINGLE-AGENT INHIBITION OF CHECKPOINT KINASE 1 (CHK1) AND 2 (CHK2) BY PF-0477736 (PFIZER) AS A NEW PROMISING THERAPY IN B-ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)	Iacobucci I; Ghelli A; Derenzini E; Imbrogno E; Ferrari A; Cattina F; Pomella S; Papayannidis C; Venturi C; Guadagnuolo V; Lonetti A; Verga Falzacappa MV; Ottaviani E; Abbenante M; Soverini S; Russo D; Pellicci PG; Baccarani M; Martinelli G	2012	HAEMATOLOGICA		4.02 Riassunto (Abstract)
14	Severe peripheral motor neuropathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin.	Pastorelli F;Derenzini E;Plasmati R;Pellegrini C;Broccoli A;Casadei B;Argnani L;Salvi F;Pileri S;Zinzani PL	2013	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
15	Sequential therapy with alternating short courses of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) and R-FM (rituximab, fludarabine, mitoxantrone) followed by autologous stem cell transplantation results in long term remission in advanced follicular lymphoma.	Derenzini, E; Casadei, B; Broccoli, A; Gandolfi, L; Pellegrini, C; Zinzani, Pl.	2014	BRITISH JOURNAL OF HAEMATOLOGY		1.01 Articolo in rivista
16	Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma	Zinzani P.L.; Stefoni V.; Tani M.; Fanti S.; Musuraca G.; Castellucci P.; Marchi E.; Fina M.; Ambrosini V.; Pellegrini C.; Alinari L.; Derenzini E.; Montini G.; Broccoli A.; Bacci F.; Pileri S.; Baccarani M.	2009	JOURNAL OF CLINICAL ONCOLOGY		1.01 Articolo in rivista
17	RALE051: a novel established cell line of sporadic Burkitt lymphoma	L'Abbate, Alberto; Iacobucci, Ilaria; Lonoce, Angelo; Turchiano, Antonella; Ficarra, Elisa; Paciello, Giulia; Cattina, Federica; Ferrari, Anna; Imbrogno, Enrica; Agostinelli, Claudio; Zinzani, Pier Luigi; Martinelli, Giovanni; Derenzini, Enrico; Storlazzi, Clelia Tiziana	2018	LEUKEMIA & LYMPHOMA		1.01 Articolo in rivista
18	Prognostic value of interim positron emission tomography in patients with peripheral T-cell lymphoma.	Pellegrini, Cinzia; Argnani, Lisa; Broccoli, Alessandro; Stefoni, Vittorio; Derenzini, Enrico; Gandolfi, Letizia; Casadei, Beatrice; Maglie, Roberto; Pileri, Stefano; Zinzani Pier, Luigi.	2014	THE ONCOLOGIST		1.01 Articolo in rivista
19	Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia	GHELLI LUSERNA DI RORÀ, Andrea; Iacobucci, Ilaria; Imbrogno, Enrica; Papayannidis, Cristina; Derenzini, Enrico; Ferrari, Anna; Guadagnuolo, Viviana; Robustelli, Valentina; Parisi, Sarah; Sartor, Chiara; Abbenante, Maria Chiara; Paolini, Stefania; Martinelli, Giovanni	2016	ONCOTARGET		1.01 Articolo in rivista
20	Pretransplantation positron emission tomography scan is the main predictor of autologous stem cell transplantation outcome in aggressive B-cell non-Hodgkin lymphoma.	Derenzini E; Musuraca G; Fanti S; Stefoni V; Tani M; Alinari L; Venturini F; Gandolfi L; Baccarani M; Zinzani PL.	2008	CANCER		1.01 Articolo in rivista